Low-Dose Naltrexone as an Adjuvant in Combined Anticancer Therapy
Marianna Ciwun, Anna Tankiewicz-Kwedlo, Dariusz Pawlak

Cancers (Basel), 2024 Mar 21;16(6):1240. https://pubmed.ncbi.nlm.nih.gov/38539570/

 

Nellmarie Bodenstein, GP - Clinical use of LDN in South Africa - 2022 Conference (LDN, low dose naltrexone)

 

 

Akbar Khan, MD - Cancer - 2020 Conference; Bahamas (LDN, low dose naltrexone)